| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.985 | 0.003 | 0.985 | Analgesic | 0.931 0.004 DBMET00866 0.985 0.003 DBMET00179 | ||
| 0.969 | 0.001 | 0.969 | Analgesic, opioid | 0.819 0.002 DBMET00866 0.948 0.002 DBMET00179 | ||
| 0.958 | 0.002 | 0.969 | Psychostimulant | 0.969 0.002 DBMET00866 0.904 0.003 DBMET00179 | DBMET00866 | |
| 0.926 | 0.001 | 0.926 | Opioid agonist | 0.765 0.002 DBMET00866 0.903 0.001 DBMET00179 | ||
| 0.906 | 0.001 | 0.906 | Opioid mu receptor agonist | 0.718 0.002 DBMET00866 0.88 0.001 DBMET00179 | ||
| 0.905 | 0.001 | 0.905 | Opioid antagonist | 0.8 0.002 DBMET00866 0.881 0.001 DBMET00179 | ||
| 0.902 | 0.001 | 0.902 | Opioid mu receptor antagonist | 0.766 0.002 DBMET00866 0.87 0.001 DBMET00179 | ||
| 0.85 | 0.001 | 0.85 | Opioid delta receptor agonist | 0.64 0.002 DBMET00866 0.82 0.002 DBMET00179 | ||
| 0.848 | 0.001 | 0.848 | Opioid delta receptor antagonist | 0.734 0.002 DBMET00866 0.825 0.001 DBMET00179 | ||
| 0.818 | 0.001 | 0.818 | Opioid kappa receptor antagonist | 0.691 0.002 DBMET00866 0.791 0.001 DBMET00179 | ||
| 0.764 | 0.003 | 0.764 | Sigma receptor antagonist | 0.273 0.007 DBMET00866 0.725 0.003 DBMET00179 | ||
| 0.754 | 0.003 | 0.754 | Anesthetic general | 0.67 0.004 DBMET00866 0.62 0.004 DBMET00179 | ||
| 0.729 | 0.001 | 0.729 | Opioid kappa receptor agonist | 0.523 0.002 DBMET00866 0.68 0.001 DBMET00179 | ||
| 0.704 | 0.007 | 0.704 | 5 Hydroxytryptamine release stimulant | 0.619 0.013 DBMET00866 0.532 0.023 DBMET00179 | ||
| 0.646 | 0.004 | 0.646 | Sigma receptor agonist | 0.531 0.007 DBMET00866 0.508 0.009 DBMET00179 | ||
| 0.629 | 0.01 | 0.673 | Spasmolytic | 0.673 0.008 DBMET00866 0.49 0.024 DBMET00179 | DBMET00866 | |
| 0.62 | 0.003 | 0.62 | Toll-Like receptor antagonist | 0.273 0.01 DBMET00866 0.567 0.003 DBMET00179 | ||
| 0.602 | 0.004 | 0.602 | Antipruritic | 0.332 0.01 DBMET00866 0.571 0.004 DBMET00179 | ||
| 0.565 | 0.001 | 0.565 | Toll-Like receptor 4 antagonist | 0.497 0.002 DBMET00866 0.561 0.001 DBMET00179 | ||
| 0.582 | 0.033 | 0.859 | Transcription factor NF kappa B inhibitor | 0.859 0.009 DBMET00866 0.548 0.038 DBMET00179 | DBMET00866 | |
| 0.482 | 0.004 | 0.482 | Acetylcholine M1 receptor antagonist | 0.171 0.058 DBMET00866 0.36 0.008 DBMET00179 | ||
| 0.385 | 0.008 | 0.385 | Cholinergic antagonist | 0.298 0.015 DBMET00179 | ||
| 0.379 | 0.005 | 0.379 | Alpha 2a adrenoreceptor antagonist | 0.371 0.005 DBMET00179 | ||
| 0.375 | 0.009 | 0.375 | Acetylcholine antagonist | 0.291 0.015 DBMET00179 | ||
| 0.341 | 0.006 | 0.341 | Alpha 2 adrenoreceptor antagonist | 0.321 0.007 DBMET00179 | ||
| 0.338 | 0.014 | 0.348 | Cholinergic | 0.159 0.07 DBMET00866 0.348 0.013 DBMET00179 | DBMET00179 | |
| 0.336 | 0.023 | 0.336 | P-glycoprotein inhibitor | 0.272 0.035 DBMET00866 0.255 0.04 DBMET00179 | ||
| 0.336 | 0.03 | 0.365 | 5 Hydroxytryptamine uptake stimulant | 0.365 0.022 DBMET00179 | DBMET00179 | |
| 0.33 | 0.035 | 0.473 | Nitric oxide antagonist | 0.473 0.018 DBMET00866 0.302 0.04 DBMET00179 | DBMET00866 | |
| 0.357 | 0.083 | 0.488 | Immunosuppressant | 0.488 0.036 DBMET00866 0.404 0.061 DBMET00179 | DBMET00866 | |
| 0.262 | 0.006 | 0.262 | Dopamine agonist | 0.093 0.03 DBMET00866 0.236 0.008 DBMET00179 | ||
| 0.263 | 0.018 | 0.263 | Acetylcholinesterase inhibitor | 0.132 0.068 DBMET00866 0.208 0.031 DBMET00179 | ||
| 0.256 | 0.014 | 0.256 | Acetylcholine muscarinic antagonist | 0.167 0.035 DBMET00179 | ||
| 0.238 | 0.005 | 0.238 | Dopamine D2 agonist | 0.126 0.008 DBMET00866 0.088 0.012 DBMET00179 | ||
| 0.318 | 0.088 | 0.318 | Vasodilator, peripheral | 0.313 0.09 DBMET00866 | ||
| 0.233 | 0.005 | 0.233 | Prolactin inhibitor | 0.208 0.008 DBMET00179 | ||
| 0.366 | 0.161 | 0.718 | Antiinflammatory | 0.718 0.028 DBMET00866 0.34 0.18 DBMET00179 | DBMET00866 | |
| 0.239 | 0.037 | 0.239 | Lipocortins synthesis antagonist | 0.207 0.052 DBMET00866 0.228 0.041 DBMET00179 | ||
| 0.199 | 0.013 | 0.199 | Acetylcholine nicotinic antagonist | 0.169 0.016 DBMET00179 | ||
| 0.18 | 0.016 | 0.198 | Breast cancer-resistant protein inhibitor | 0.198 0.014 DBMET00179 | DBMET00179 | |
| 0.183 | 0.019 | 0.183 | Antineoplastic alkaloid | 0.092 0.053 DBMET00866 0.157 0.026 DBMET00179 | ||
| 0.168 | 0.013 | 0.168 | Dopamine D1 antagonist | 0.091 0.028 DBMET00179 | ||
| 0.179 | 0.024 | 0.179 | Nav1.1 sodium channel blocker | 0.09 0.08 DBMET00179 | ||
| 0.236 | 0.082 | 0.253 | Tyrosine 3 hydroxylase inhibitor | 0.253 0.065 DBMET00179 | DBMET00179 | |
| 0.211 | 0.059 | 0.39 | Hepatoprotectant | 0.39 0.014 DBMET00866 0.183 0.078 DBMET00179 | DBMET00866 | |
| 0.25 | 0.1 | 0.25 | Hypoxia-inducible factor 1 alpha inhibitor | 0.237 0.112 DBMET00866 0.191 0.163 DBMET00179 | ||
| 0.261 | 0.117 | 0.261 | Sodium/bile acid cotransporter inhibitor | 0.257 0.121 DBMET00179 | ||
| 0.171 | 0.032 | 0.171 | Alpha adrenoreceptor antagonist | 0.131 0.043 DBMET00179 | ||
| 0.17 | 0.033 | 0.434 | Cyclooxygenase 3 inhibitor | 0.434 0.004 DBMET00866 0.201 0.018 DBMET00179 | DBMET00866 | |
| 0.23 | 0.095 | 0.543 | Antioxidant | 0.543 0.016 DBMET00866 0.263 0.077 DBMET00179 | DBMET00866 | |
| 0.134 | 0.003 | 0.134 | Prolactin release inhibitor | 0.102 0.004 DBMET00866 0.103 0.004 DBMET00179 | ||
| 0.142 | 0.013 | 0.142 | Neuronal nicotinic receptor antagonist | 0.125 0.016 DBMET00179 | ||
| 0.134 | 0.007 | 0.134 | Dopamine D5 antagonist | 0.085 0.011 DBMET00179 | ||
| 0.136 | 0.014 | 0.136 | Alpha 2d adrenoreceptor antagonist | 0.093 0.063 DBMET00866 0.134 0.015 DBMET00179 | ||
| 0.141 | 0.024 | 0.141 | Acetylcholine M3 receptor agonist | 0.14 0.024 DBMET00179 | ||
| 0.174 | 0.06 | 0.219 | Interleukin 6 antagonist | 0.219 0.031 DBMET00866 | DBMET00866 | |
| 0.167 | 0.058 | 0.434 | NOS3 expression enhancer | 0.434 0.007 DBMET00866 0.141 0.082 DBMET00179 | DBMET00866 | |
| 0.163 | 0.055 | 0.202 | Toll-Like receptor 9 antagonist | 0.202 0.035 DBMET00179 | DBMET00179 | |
| 0.112 | 0.005 | 0.112 | Nociceptin (N/OFQ) receptor antagonist | 0.076 0.008 DBMET00179 | ||
| 0.233 | 0.128 | 0.235 | Caspase 3 stimulant | 0.235 0.126 DBMET00866 | DBMET00866 | |
| 0.162 | 0.06 | 0.293 | Protein kinase stimulant | 0.293 0.018 DBMET00866 0.156 0.064 DBMET00179 | DBMET00866 | |
| 0.128 | 0.03 | 0.128 | Dopamine antagonist | 0.069 0.054 DBMET00179 | ||
| 0.234 | 0.137 | 0.383 | Interleukin 2 agonist | 0.383 0.033 DBMET00866 0.241 0.129 DBMET00179 | DBMET00866 | |
| 0.198 | 0.105 | 0.198 | Aldehyde oxidase inhibitor | |||
| 0.194 | 0.103 | 0.476 | Free radical scavenger | 0.476 0.018 DBMET00866 0.194 0.103 DBMET00179 | DBMET00866 | |
| 0.183 | 0.094 | 0.193 | Neurotrophic factor enhancer | 0.193 0.083 DBMET00866 0.175 0.104 DBMET00179 | DBMET00866 | |
| 0.129 | 0.04 | 0.13 | Estrogen antagonist | 0.13 0.038 DBMET00179 | DBMET00179 | |
| 0.12 | 0.032 | 0.12 | Estrogen receptor beta antagonist | 0.118 0.035 DBMET00179 | ||
| 0.129 | 0.044 | 0.129 | Alpha 2c adrenoreceptor antagonist | 0.1 0.066 DBMET00179 | ||
| 0.124 | 0.038 | 0.124 | Creatine kinase inhibitor | 0.114 0.045 DBMET00179 | ||
| 0.072 | 0.003 | 0.092 | NMDA receptor phencyclidine site antagonist | 0.092 0.002 DBMET00179 | DBMET00179 | |
| 0.189 | 0.123 | 0.568 | Hypoglycemic | 0.568 0.01 DBMET00866 | DBMET00866 | |
| 0.116 | 0.053 | 0.116 | Electron transport complex I inhibitor | 0.105 0.072 DBMET00179 | ||
| 0.116 | 0.053 | 0.354 | Expectorant | 0.354 0.006 DBMET00866 0.101 0.067 DBMET00179 | DBMET00866 | |
| 0.138 | 0.081 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.131 0.116 DBMET00866 0.131 0.114 DBMET00179 | ||
| 0.106 | 0.052 | 0.106 | Antiadrenergic | 0.105 0.053 DBMET00179 | ||
| 0.064 | 0.011 | 0.104 | Nicotinic receptor beta4 subunit antagonist | 0.104 0.006 DBMET00179 | DBMET00179 | |
| 0.079 | 0.026 | 0.079 | NMDA 2C receptor antagonist | 0.075 0.028 DBMET00179 | ||
| 0.055 | 0.004 | 0.089 | Dopamine D1 agonist | 0.046 0.005 DBMET00866 0.089 0.003 DBMET00179 | DBMET00179 | |
| 0.098 | 0.055 | 0.098 | Adrenaline antagonist | 0.098 0.055 DBMET00179 | ||
| 0.064 | 0.025 | 0.064 | Nicotinic receptor alpha7 subunit antagonist | 0.061 0.028 DBMET00179 | ||
| 0.056 | 0.025 | 0.112 | Nicotinic receptor alpha4 subunit antagonist | 0.112 0.006 DBMET00179 | DBMET00179 | |
| 0.06 | 0.029 | 0.06 | Acetylcholine M2 receptor agonist | 0.052 0.041 DBMET00179 | ||
| 0.103 | 0.073 | 0.103 | Cystathionine beta-synthase inhibitor | |||
| 0.121 | 0.092 | 0.21 | Lipid peroxidase inhibitor | 0.21 0.038 DBMET00866 0.148 0.07 DBMET00179 | DBMET00866 | |
| 0.071 | 0.043 | 0.071 | Dopamine D2 antagonist | |||
| 0.035 | 0.009 | 0.04 | Nociceptin (N/OFQ) receptor agonist | 0.04 0.007 DBMET00179 | DBMET00179 | |
| 0.133 | 0.108 | 0.168 | Melanin inhibitor | 0.168 0.061 DBMET00866 0.162 0.067 DBMET00179 | DBMET00866 | |
| 0.045 | 0.02 | 0.045 | Estrogen receptor beta agonist | 0.045 0.02 DBMET00179 | ||
| 0.082 | 0.058 | 0.082 | CC chemokine 5 receptor agonist | 0.082 0.056 DBMET00179 | ||
| 0.058 | 0.04 | 0.068 | Lipocortins synthesis agonist | 0.068 0.023 DBMET00866 0.059 0.039 DBMET00179 | DBMET00866 | |
| 0.16 | 0.143 | 0.277 | Vasodilator | 0.277 0.056 DBMET00866 0.159 0.144 DBMET00179 | DBMET00866 | |
| 0.096 | 0.079 | 0.096 | Alpha 2b adrenoreceptor antagonist | |||
| 0.08 | 0.066 | 0.08 | Acetylcholine agonist | 0.078 0.068 DBMET00179 | ||
| 0.049 | 0.036 | 0.049 | Estrogen agonist | 0.046 0.038 DBMET00866 0.044 0.039 DBMET00179 | ||
| 0.043 | 0.031 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.069 | 0.057 | 0.076 | Glycine receptor agonist | 0.076 0.045 DBMET00179 | DBMET00179 | |
| 0.126 | 0.118 | 0.137 | Arachidonic acid antagonist | 0.137 0.103 DBMET00179 | DBMET00179 | |
| 0.036 | 0.031 | 0.039 | Glucose-6-phosphate dehydrogenase inhibitor | 0.039 0.024 DBMET00179 | DBMET00179 | |
| 0.094 | 0.09 | 0.122 | Adenylate cyclase inhibitor | 0.122 0.066 DBMET00179 | DBMET00179 | |
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.043 | 0.04 | 0.043 | Dopamine transporter inhibitor | |||
| 0.034 | 0.031 | 0.062 | NMDA receptor subunit 3A antagonist | 0.062 0.016 DBMET00179 | DBMET00179 | |
| 0.026 | 0.024 | 0.027 | RNA-directed RNA polymerase stimulant | 0.027 0.023 DBMET00179 | DBMET00179 | |
| 0.105 | 0.104 | 0.105 | Nav1.2 sodium channel blocker | |||
| 0.065 | 0.065 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.1 0.032 DBMET00866 0.091 0.04 DBMET00179 | DBMET00866 | |
| 0.086 | 0.086 | 0.088 | Anabolic | 0.088 0.082 DBMET00179 | DBMET00179 | |
| 0.249 | 0.255 | 0.261 | Caspase 9 stimulant | 0.261 0.239 DBMET00866 | DBMET00866 | |
| 0.23 | 0.237 | 0.453 | Apoptosis agonist | 0.453 0.09 DBMET00866 | DBMET00866 | |
| 0.069 | 0.079 | 0.087 | Androgen antagonist | 0.087 0.058 DBMET00179 | DBMET00179 | |
| 0.068 | 0.078 | 0.103 | Glycine receptor antagonist | 0.103 0.03 DBMET00866 0.074 0.067 DBMET00179 | DBMET00866 | |
| 0.145 | 0.159 | 0.424 | Immunostimulant | 0.424 0.043 DBMET00866 | DBMET00866 | |
| 0.059 | 0.074 | 0.168 | Antineoplastic antibiotic | 0.168 0.027 DBMET00866 | DBMET00866 | |
| 0.029 | 0.049 | 0.109 | Dopamine D5 agonist | 0.109 0.004 DBMET00179 | DBMET00179 | |
| 0.05 | 0.076 | 0.075 | NMDA 2 receptor antagonist | 0.075 0.047 DBMET00179 | DBMET00179 | |
| 0.189 | 0.216 | 0.376 | Histamine release inhibitor | 0.376 0.088 DBMET00866 | DBMET00866 | |
| 0.037 | 0.065 | 0.057 | Aromatase inhibitor | 0.057 0.044 DBMET00179 | DBMET00179 | |
| 0.043 | 0.072 | 0.056 | Androgen agonist | 0.056 0.047 DBMET00179 | DBMET00179 | |
| 0.057 | 0.109 | 0.103 | NMDA receptor antagonist | 0.103 0.045 DBMET00179 | DBMET00179 | |
| 0.172 | 0.226 | 0.332 | Apoptosis antagonist | 0.332 0.065 DBMET00866 | DBMET00866 | |
| 0.184 | 0.239 | 0.207 | Calcium channel activator | 0.207 0.203 DBMET00179 | DBMET00179 | |
| 0.022 | 0.081 | 0.052 | NMDA 2A receptor antagonist | 0.052 0.035 DBMET00179 | DBMET00179 | |
| 0.07 | 0.142 | 0.119 | Alkylator | 0.119 0.069 DBMET00866 | DBMET00866 | |
| 0.103 | 0.186 | 0.171 | Interferon gamma antagonist | 0.171 0.056 DBMET00866 | DBMET00866 | |
| 0.011 | 0.106 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.013 DBMET00866 | DBMET00866 | |
| 0.023 | 0.119 | 0.082 | Protein 50S ribosomal subunit inhibitor | 0.082 0.019 DBMET00866 | DBMET00866 | |
| 0.061 | 0.158 | 0.102 | DNA polymerase I inhibitor | 0.102 0.084 DBMET00866 | DBMET00866 | |
| 0.082 | 0.188 | 0.154 | Diuretic | 0.154 0.074 DBMET00866 | DBMET00866 | |
| 0.094 | 0.2 | 0.137 | Adenylate cyclase stimulant | 0.137 0.087 DBMET00179 | DBMET00179 | |
| 0.058 | 0.165 | 0.096 | Cholesterol synthesis inhibitor | 0.096 0.094 DBMET00179 | DBMET00179 | |
| 0.006 | 0.115 | 0.034 | Arginase inhibitor | 0.034 0.028 DBMET00866 | DBMET00866 | |
| 0.01 | 0.126 | 0.047 | 5 Hydroxytryptamine 2C agonist | 0.047 0.03 DBMET00179 | DBMET00179 | |
| 0.02 | 0.146 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET00866 | DBMET00866 | |
| 0.123 | 0.27 | 0.226 | DNA synthesis inhibitor | 0.226 0.087 DBMET00866 0.208 0.112 DBMET00179 | DBMET00866 | |
| 0.026 | 0.18 | 0.064 | Glucose-6-phosphate translocase inhibitor | 0.064 0.02 DBMET00866 | DBMET00866 | |
| 0.127 | 0.29 | 0.472 | Antithrombotic | 0.472 0.033 DBMET00866 | DBMET00866 | |
| 0.048 | 0.226 | 0.121 | AMP-activated protein kinase stimulant | 0.121 0.048 DBMET00866 | DBMET00866 | |
| 0.019 | 0.203 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.043 DBMET00866 | DBMET00866 | |
| 0.091 | 0.302 | 0.182 | Cyclic AMP phosphodiesterase inhibitor | 0.182 0.109 DBMET00866 | DBMET00866 | |
| 0.096 | 0.325 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.071 DBMET00866 | DBMET00866 | |
| 0.101 | 0.331 | 0.243 | Cholesterol antagonist | 0.243 0.13 DBMET00866 | DBMET00866 | |
| 0.113 | 0.343 | 0.321 | Peptidyltransferase inhibitor | 0.321 0.018 DBMET00866 | DBMET00866 | |
| 0.049 | 0.291 | 0.462 | Angiogenesis stimulant | 0.462 0.014 DBMET00866 | DBMET00866 | |
| 0.069 | 0.327 | 0.292 | Tumour necrosis factor alpha release inhibitor | 0.292 0.057 DBMET00866 | DBMET00866 | |
| 0.059 | 0.319 | 0.193 | Interleukin agonist | 0.193 0.128 DBMET00866 | DBMET00866 | |
| 0.028 | 0.308 | 0.114 | Topoisomerase II inhibitor | 0.114 0.073 DBMET00866 | DBMET00866 | |
| 0.135 | 0.443 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET00179 | DBMET00179 | |
| 0.091 | 0.413 | 0.25 | Vasodilator, coronary | 0.25 0.135 DBMET00866 | DBMET00866 | |
| 0.02 | 0.356 | 0.106 | Topoisomerase I inhibitor | 0.106 0.065 DBMET00866 | DBMET00866 | |
| 0.051 | 0.401 | 0.163 | Hemostatic | 0.163 0.054 DBMET00866 | DBMET00866 | |
| 0.022 | 0.4 | 0.09 | ATPase (Vacuolar H+) inhibitor | 0.09 0.057 DBMET00866 | DBMET00866 | |
| 0.075 | 0.456 | 0.321 | Immunomodulator | 0.321 0.071 DBMET00866 | DBMET00866 | |
| 0.012 | 0.396 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET00866 | DBMET00866 | |
| 0.035 | 0.472 | 0.089 | Transcription factor NF kappa B stimulant | 0.089 0.053 DBMET00866 | DBMET00866 | |
| 0.036 | 0.488 | 0.227 | Platelet adhesion inhibitor | 0.227 0.058 DBMET00866 | DBMET00866 | |
| 0.069 | 0.569 | 0.593 | Cyclophilin D inhibitor | 0.593 0.029 DBMET00866 | DBMET00866 | |
| 0.045 | 0.573 | 0.439 | Antibacterial | 0.439 0.061 DBMET00866 | DBMET00866 | |
| 0.025 | 0.583 | 0.235 | Insulin secretagoues | 0.235 0.023 DBMET00866 | DBMET00866 | |
| 0.016 | 0.629 | 0.163 | Platelet antagonist | 0.163 0.131 DBMET00866 | DBMET00866 | |
| 0.005 | 0.625 | 0.212 | Selectin antagonist | 0.212 0.01 DBMET00866 | DBMET00866 | |
| 0.011 | 0.764 | 0.117 | Cell adhesion inhibitor | 0.117 0.067 DBMET00866 | DBMET00866 | |
| 0.009 | 0.788 | 0.139 | Thrombolytic | 0.139 0.09 DBMET00866 | DBMET00866 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |